[1]
Kaur, N. et al. 2024. Comparative Evaluation of Vildagliptin-Metformin Versus Glimepiride-Metformin on Inflammatory Markers and Glycemic Control in Type 2 Diabetes Mellitus: A Randomized, Open-Label Study. JK Science: Journal of Medical Education & Research. 26, 3 (Jul. 2024), 160–164.